GHK-Cu care map

Weigh a copper peptide offer

After the first conversation

Keep later care in the cost picture.

Follow-up means care after the first visit. Ask who you can reach, what is included and what could be billed again.

Ask how later answers and charges work.

Medical-board guidance checked September 26, 2026 says patients need access to their clinician for questions after a visit.

That guidance does not set a fee or promise a response time.

Ask the service to spell out its own arrangements. Save that answer with the written quote.

Put the support terms on the same sheet.

  • Who answers a health question after the first visit?
  • How do I reach that person?
  • Are messages included, or could they trigger another visit fee?
  • What does a review visit include?
  • Who explains a repeat test, and is that a separate charge?
  • What happens if the clinician changes the proposed plan?

Ask for the service’s expected response time. If the answer uses “support,” ask whether it means a clinician or someone handling bills.

A repeating charge needs a clear ending.

If an offer renews, ask what renews: the support fee, the product charge or both. Ask how to stop a renewal and what remains due.

You can ask the clinician how the plan will be reviewed and what would lead to stopping it.

GHK-Cu had no official test checklist for planning later visits as of September 30, 2026. It had no medicine label reviewed by the U.S. Food and Drug Administration (FDA).

Before relying on a preset calendar, ask why that particular review plan was proposed.

The basis for access to questions.

Medical-board guidance supports the expectation of a continuing conversation; FDA records explain the missing label.